Neighbourly Pharmacy Inc T.NBLY

$20.5-$25.5 is TD's fair value opinion

[Kanatainvestor]

This new offer is below TD's $20.5-$25.5 fair value opinion which was mentioned in the original buyout offer press release on October 3rd. Since then, long term interest rates have declined substantially and the valuation of roll-up strategy companies re-valued notably higher; I don’t see how the Board can accept this offer without exposing itself to legal liability. In my opinion, this deal will only go through if PCP delivers on the original letter of intent.

[StewartCatso]

On November 13, 2023 The Company has agreed to extend the previously announced exclusivity period granted to PCP to January 15, 2024 to complete negotiation of a definitive agreement for the Proposed Transaction and to allow PCP to finalize its equity financing arrangements for the Proposed Transaction. The entering into of a definitive agreement concerning the Proposed